Beta-lactamases and inhibitors: Evidence for a post-β-lactamases-inhibitory effect of clavulanic acid against H. influenzae, K. pneumoniae and E. coli

Antibiotiques

Volumn 3, Issue 1, 2001, Pages 35-41

  Murbach, V ^a   Bronner, S ^a   Linger, L ^a   Dhoyen, N ^a   Sougakoff, W ^a   Monteil, H ^a   Jehl, F ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

lactamases; Clavulanic acid; Post lactamases inhibitory effect (PLIE)

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CLAVULANIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME INHIBITION; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE; POSTANTIBIOTIC EFFECT;

EID: 0035101360     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. β-lactamase inhibitors from laboratory to clinic
2. Effect of low concentrations of clavulanic acid on the in vitro activity of amoxycillin against β-lactamase producing Branhamella catarrhalis and Haemophilus influenzae
3. Comparison de l'activité in vitro des associations amoxicilline + acide clavulanique et ampicilline + sulbactam sur cinquate souches de Haemophilus influenzae productrices d'une bêta-lactamase
4. Parenteral Augmentin: Pharmacokinetics
5. Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges
6. Pharmacodynamics of piperacillin alone and combination with tazobactam against piperacillin-resistant and -susceptible organisms in an vitro model of infection
7. The post-antibiotic effect
8. Mise en évidence in vitro d'un effet post-inhibiteur de bêta-lactamases (EPIBLA) de l'acide clavulanique sur Klebsiella pneumoniae et Haemophilus influenzae
9. Détermination de la concentration minimale inhibitrice et de la concentration minimale bactéricide en milieu liquide. MPC- Videom éditeur
10. Post-antibiotic effects of cefdinir on E. coli, K. pneumoniae, S. aureus, and S. pyogenes
11. Post-antibiotic and post-β-lactamase inhibitor effects of amoxicillin plus clavulanate
12. Single dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients
13. Efficacy of twice daily dosing of amoxicillin/clavulanate in acute otitis media in children
14. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatement of lower respiratory tract infection
15. In vitro bacterial killing kinetics of ticarcillin/clavulanic acid
16. Efficacy of Ampicillin - Sulbactam is not dependent upon maintenance of a critical ratio between components: Sulbactam pharmacokinetics in pharmacodynamic interactions
17. In vitro assessment of the effect of clavulanic acid at concentration achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against S. aureus: Implications for dosage regimens